Morgan Stanley’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$411M Buy
4,547,219
+2,061,306
+83% +$175M 0.02% 665
2026
Q1
$208M Buy
2,485,913
+999,856
+67% +$82M 0.01% 925
2025
Q4
$136M Buy
1,486,057
+183,645
+14% +$17.6M 0.01% 1188
2025
Q3
$123M Sell
1,302,412
-101,756
-7% -$9.58M 0.01% 1239
2025
Q2
$147M Sell
1,404,168
-3,126
-0.2% -$296K 0.01% 1061
2025
Q1
$124M Buy
1,407,294
+610,647
+77% +$62.6M 0.01% 1094
2024
Q4
$76.4M Buy
796,647
+91,392
+13% +$8.52M 0.01% 1461
2024
Q3
$57.7M Buy
705,255
+66,941
+10% +$5.16M ﹤0.01% 1693
2024
Q2
$55M Sell
638,314
-2,741
-0.4% -$221K ﹤0.01% 1675
2024
Q1
$52.3M Sell
641,055
-151,779
-19% -$11.9M ﹤0.01% 1714
2023
Q4
$52.6M Buy
792,834
+91,818
+13% +$6.37M ﹤0.01% 1671
2023
Q3
$51.2M Buy
701,016
+55,296
+9% +$3.74M 0.01% 1559
2023
Q2
$40.8M Buy
645,720
+78,511
+14% +$4.55M ﹤0.01% 1767
2023
Q1
$33.3M Buy
567,209
+62,374
+12% +$3.79M ﹤0.01% 1916
2022
Q4
$31.1M Sell
504,835
-53,483
-10% -$3.59M ﹤0.01% 1926
2022
Q3
$37.5M Sell
558,318
-12,178
-2% -$771K 0.01% 1550
2022
Q2
$35M Buy
570,496
+426,599
+296% +$27.3M ﹤0.01% 1690
2022
Q1
$9.7M Sell
143,897
-27,123
-16% -$1.46M ﹤0.01% 2935
2021
Q4
$7.57M Sell
171,020
-219,946
-56% -$12.8M ﹤0.01% 3268
2021
Q3
$25.3M Sell
390,966
-285,696
-42% -$19.8M ﹤0.01% 1841
2021
Q2
$54.5M Buy
676,662
+386,663
+133% +$29.5M 0.01% 1251
2021
Q1
$19.7M Buy
289,999
+19,625
+7% +$1.54M ﹤0.01% 1927
2020
Q4
$18.8M Buy
270,374
+36,847
+16% +$2.29M ﹤0.01% 1859
2020
Q3
$12M Sell
233,527
-59,747
-20% -$3.28M ﹤0.01% 1882
2020
Q2
$17.2M Buy
293,274
+118,303
+68% +$6.54M ﹤0.01% 1525
2020
Q1
$8.85M Sell
174,971
-971,281
-85% -$64.5M ﹤0.01% 1897
2019
Q4
$84.9M Buy
1,146,252
+68,857
+6% +$4.3M 0.02% 674
2019
Q3
$61.6M Sell
1,077,395
-311,952
-22% -$20.7M 0.02% 750
2019
Q2
$90.9M Sell
1,389,347
-5,126,923
-79% -$357M 0.02% 586
2019
Q1
$482M Buy
6,516,270
+89,576
+1% +$6.3M 0.14% 160
2018
Q4
$383M Buy
6,426,694
+2,425,269
+61% +$195M 0.11% 186
2018
Q3
$378M Buy
4,001,425
+536,366
+15% +$46.2M 0.09% 221
2018
Q2
$260M Sell
3,465,059
-41,757
-1% -$3M 0.07% 278
2018
Q1
$212M Buy
3,506,816
+2,188,901
+166% +$119M 0.06% 322
2017
Q4
$61.5M Buy
1,317,915
+121,853
+10% +$6.03M 0.02% 808
2017
Q3
$60.5M Buy
1,196,062
+284,875
+31% +$13.3M 0.02% 798
2017
Q2
$45.4M Sell
911,187
-7,821
-0.9% -$366K 0.01% 963
2017
Q1
$39M Sell
919,008
-400,592
-30% -$17.7M 0.01% 1066
2016
Q4
$53.5M Buy
1,319,600
+455,873
+53% +$17.6M 0.02% 832
2016
Q3
$32.7M Sell
863,727
-16,563
-2% -$525K 0.01% 1100
2016
Q2
$26.7M Sell
880,290
-173,940
-16% -$4.57M 0.01% 1197
2016
Q1
$26M Sell
1,054,230
-675,890
-39% -$14.5M 0.01% 1154
2015
Q4
$43.4M Sell
1,730,120
-887,432
-34% -$27.3M 0.02% 868
2015
Q3
$77.3M Buy
2,617,552
+1,492,086
+133% +$46.9M 0.03% 581
2015
Q2
$36.1M Sell
1,125,466
-48,753
-4% -$1.31M 0.01% 1057
2015
Q1
$29.3M Sell
1,174,219
-162,860
-12% -$3.53M 0.01% 1167
2014
Q4
$34M Sell
1,337,079
-128,033
-9% -$2.78M 0.01% 1083
2014
Q3
$26.8M Buy
+1,465,112
New +$28.1M 0.01% 1209

Other funds holding HQY

Morgan Stanley's HQY Position: Q2 2026 in Review

Morgan Stanley increased its HealthEquity (HQY) stake by 83% in Q2 2026, buying an estimated $175M and bringing the position to 4,547,219 shares worth $411M. The position accounts for 0.02% of the portfolio, ranked #665.

Morgan Stanley first reported a position in HQY in Q3 2014 and has held it in 48 quarters since. The position peaked at $482M in Q1 2019. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Morgan Stanley held 4,547,219 shares of HealthEquity worth $411M as of Q2 2026.
  • Morgan Stanley bought 2,061,306 HealthEquity shares in Q2 2026, an estimated $175M.
  • HealthEquity made up 0.02% of Morgan Stanley's portfolio in Q2 2026, its #665 holding.
  • Morgan Stanley first reported a position in HealthEquity in Q3 2014 and has held it in 48 quarters since.
  • Morgan Stanley's HealthEquity position peaked at $482M in Q1 2019.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.